plerixafor has been researched along with ziconotide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Binda, NS; Cecilia, FS; da Silva Junior, CA; da Silva, JF; de Castro Junior, CJ; Diniz, DM; do Nascimento Cordeiro, M; Ferreira, J; Gomez, MV; Pereira, EMR | 1 |
1 other study(ies) available for plerixafor and ziconotide
Article | Year |
---|---|
The inhibitory effect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor.
Topics: Analgesics; Animals; Benzylamines; Calcium; Calcium Channels; Chemokine CXCL12; Cyclams; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Heterocyclic Compounds; omega-Conotoxins; Rats; Rats, Wistar; Receptors, CXCR4; Spider Venoms | 2020 |